2,728
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma

, MD, , MD, , MBBS, M Med(Ophth), FRCS(Glasg), FRCS(Ed), FRCOphthORCID Icon, , MD, , FRCS, MMed, DNB, DOORCID Icon, , MScORCID Icon, , MD, , BSc MBChB DO FRCSEd FRCOphth, , MD, PhDORCID Icon, , MD, , MD, MPH, , MS, FAMS, FIC Path, FAICO, , MDORCID Icon, , MD, , MD, PhDORCID Icon, , MD, PhDORCID Icon, , MD, , MD, MPH, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, MHS, , , MD, , MD, PhDORCID Icon, , MD, , MBBS, PhD, , MD, MBA, MPH, , MD, FRANZCO, PhD, FARVOORCID Icon, , MD, PhD, , MD, PhD & show all
Pages 507-520 | Received 23 Sep 2020, Accepted 12 Jan 2021, Published online: 19 May 2021
 

ABSTRACT

Purpose

To provide recommendations for diagnosis of vitreoretinal lymphoma (VRL).

Methods

Literature was reviewed for reports supporting the diagnosis of VRL. A questionnaire (Delphi 1 round) was distributed to 28 participants. In the second round (Delphi 2), items of the questionnaire not reaching consensus (75% agreement) were discussed to finalize the recommendations.

Results

Presenting symptoms include floaters and painless loss of vision, vitreous cells organized into sheets or clumps. Retinal lesions are usually multifocal creamy/white in the outer retina. Other findings include retinal lesions with “leopard-skin” appearance and retinal pigment epithelium atrophy. Severe vitreous infiltration without macular edema is the most likely presentation. Diagnostic vitrectomy should be performed. Systemic corticosteroid should be discontinued at least 2 weeks before surgery. An interleukin (IL)-10:IL-6 ratio > 1, positive mutation for the myeloid differentiation primary response 88 gene and monoclonality are indicators of VRL. Multi-modal imaging (optical coherence tomography, fundus autofluorescence) are recommended.

Conclusions

A consensus meeting allowed the establishment of recommendations important for the diagnosis of VRL.

Supplementary material

Supplemental data for this article can be accessed on the publisher’s website.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.